BioLife Solutions, Inc. (BLFS)
USD 24.98
(-7.03%)
USD 24.98
(-7.03%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 75.05 Million USD | -12.77% |
| 2022 | 86.04 Million USD | 19.75% |
| 2021 | 71.85 Million USD | 142.89% |
| 2020 | 29.58 Million USD | 196.27% |
| 2019 | 9.98 Million USD | 330.57% |
| 2018 | 2.31 Million USD | 13.07% |
| 2017 | 2.05 Million USD | -56.92% |
| 2016 | 4.76 Million USD | 89.66% |
| 2015 | 2.51 Million USD | 17.49% |
| 2014 | 2.13 Million USD | -87.15% |
| 2013 | 16.62 Million USD | 6.19% |
| 2012 | 15.65 Million USD | 21.91% |
| 2011 | 12.84 Million USD | 18.28% |
| 2010 | 10.85 Million USD | 18.52% |
| 2009 | 9.16 Million USD | 44.45% |
| 2008 | 6.34 Million USD | 98.44% |
| 2007 | 3.19 Million USD | 740.25% |
| 2006 | 380.34 Thousand USD | -6.92% |
| 2005 | 408.62 Thousand USD | 85.48% |
| 2004 | 220.31 Thousand USD | -86.3% |
| 2003 | 1.6 Million USD | 85.21% |
| 2002 | 868.09 Thousand USD | -40.78% |
| 2001 | 1.46 Million USD | 306.87% |
| 2000 | 360.26 Thousand USD | -73.13% |
| 1999 | 1.34 Million USD | 3.46% |
| 1998 | 1.29 Million USD | -8.65% |
| 1997 | 1.41 Million USD | -30.81% |
| 1996 | 2.05 Million USD | -53.62% |
| 1995 | 4.42 Million USD | 16.34% |
| 1994 | 3.8 Million USD | 35.71% |
| 1993 | 2.8 Million USD | 180.0% |
| 1992 | 1 Million USD | 900.0% |
| 1991 | 100 Thousand USD | -50.0% |
| 1990 | 200 Thousand USD | -50.0% |
| 1989 | 400 Thousand USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 53.53 Million USD | -21.5% |
| 2024 Q1 | 68.19 Million USD | -9.13% |
| 2023 Q1 | 88.36 Million USD | 2.7% |
| 2023 Q2 | 81.04 Million USD | -8.28% |
| 2023 FY | 75.05 Million USD | -12.77% |
| 2023 Q4 | 75.05 Million USD | -5.16% |
| 2023 Q3 | 79.13 Million USD | -2.36% |
| 2022 Q1 | 65.49 Million USD | -8.85% |
| 2022 Q3 | 79.43 Million USD | 36.79% |
| 2022 Q2 | 58.06 Million USD | -11.34% |
| 2022 FY | 86.04 Million USD | 19.75% |
| 2022 Q4 | 86.04 Million USD | 8.32% |
| 2021 FY | 71.85 Million USD | 142.89% |
| 2021 Q1 | 31.24 Million USD | 5.62% |
| 2021 Q2 | 68.68 Million USD | 119.82% |
| 2021 Q3 | 70.13 Million USD | 2.1% |
| 2021 Q4 | 71.85 Million USD | 2.45% |
| 2020 FY | 29.58 Million USD | 196.27% |
| 2020 Q3 | 9.03 Million USD | 11.18% |
| 2020 Q1 | 27.27 Million USD | 173.19% |
| 2020 Q2 | 8.12 Million USD | -70.21% |
| 2020 Q4 | 29.58 Million USD | 227.39% |
| 2019 FY | 9.98 Million USD | 330.57% |
| 2019 Q2 | 5.47 Million USD | 47.72% |
| 2019 Q4 | 9.98 Million USD | 37.42% |
| 2019 Q3 | 7.26 Million USD | 32.69% |
| 2019 Q1 | 3.7 Million USD | 59.85% |
| 2018 FY | 2.31 Million USD | 13.07% |
| 2018 Q4 | 2.31 Million USD | -7.95% |
| 2018 Q3 | 2.51 Million USD | 18.17% |
| 2018 Q2 | 2.13 Million USD | 17.03% |
| 2018 Q1 | 1.82 Million USD | -11.18% |
| 2017 Q3 | 1.66 Million USD | 0.37% |
| 2017 FY | 2.05 Million USD | -56.92% |
| 2017 Q4 | 2.05 Million USD | 23.04% |
| 2017 Q2 | 1.66 Million USD | -71.34% |
| 2017 Q1 | 5.79 Million USD | 21.72% |
| 2016 Q1 | 2.24 Million USD | -10.53% |
| 2016 FY | 4.76 Million USD | 89.66% |
| 2016 Q3 | 4.17 Million USD | 39.07% |
| 2016 Q4 | 4.76 Million USD | 13.95% |
| 2016 Q2 | 3 Million USD | 33.77% |
| 2015 Q4 | 2.51 Million USD | 2.83% |
| 2015 Q2 | 1.99 Million USD | -13.81% |
| 2015 Q1 | 2.31 Million USD | 8.23% |
| 2015 FY | 2.51 Million USD | 17.49% |
| 2015 Q3 | 2.44 Million USD | 22.48% |
| 2014 Q1 | 1.9 Million USD | -88.54% |
| 2014 Q3 | 1.58 Million USD | 12.69% |
| 2014 Q2 | 1.4 Million USD | -26.06% |
| 2014 FY | 2.13 Million USD | -87.15% |
| 2014 Q4 | 2.13 Million USD | 34.64% |
| 2013 Q3 | 16.06 Million USD | -0.21% |
| 2013 Q1 | 15.81 Million USD | 1.05% |
| 2013 FY | 16.62 Million USD | 6.19% |
| 2013 Q4 | 16.62 Million USD | 3.48% |
| 2013 Q2 | 16.09 Million USD | 1.77% |
| 2012 FY | 15.65 Million USD | 21.91% |
| 2012 Q4 | 15.65 Million USD | 1.31% |
| 2012 Q3 | 15.45 Million USD | 4.35% |
| 2012 Q2 | 14.8 Million USD | 11.35% |
| 2012 Q1 | 13.29 Million USD | 3.56% |
| 2011 FY | 12.84 Million USD | 18.28% |
| 2011 Q1 | 11.48 Million USD | 5.79% |
| 2011 Q2 | 11.95 Million USD | 4.08% |
| 2011 Q3 | 12.38 Million USD | 3.6% |
| 2011 Q4 | 12.84 Million USD | 3.69% |
| 2010 Q1 | 9.65 Million USD | 5.34% |
| 2010 FY | 10.85 Million USD | 18.52% |
| 2010 Q3 | 10.51 Million USD | 3.04% |
| 2010 Q4 | 10.85 Million USD | 3.29% |
| 2010 Q2 | 10.2 Million USD | 5.71% |
| 2009 FY | 9.16 Million USD | 44.45% |
| 2009 Q1 | 7.72 Million USD | 21.86% |
| 2009 Q4 | 9.16 Million USD | 4.0% |
| 2009 Q2 | 8.16 Million USD | 5.66% |
| 2009 Q3 | 8.8 Million USD | 7.87% |
| 2008 Q4 | 6.34 Million USD | 11.51% |
| 2008 FY | 6.34 Million USD | 98.44% |
| 2008 Q2 | 4.58 Million USD | 16.35% |
| 2008 Q3 | 5.68 Million USD | 23.93% |
| 2008 Q1 | 3.94 Million USD | 23.41% |
| 2007 Q4 | 3.19 Million USD | -1.41% |
| 2007 Q1 | 1.05 Million USD | 176.67% |
| 2007 Q2 | 2.2 Million USD | 109.65% |
| 2007 Q3 | 3.24 Million USD | 46.94% |
| 2007 FY | 3.19 Million USD | 740.25% |
| 2006 Q1 | 439.03 Thousand USD | 7.44% |
| 2006 Q4 | 380.34 Thousand USD | -30.88% |
| 2006 Q2 | 356.97 Thousand USD | -18.69% |
| 2006 FY | 380.34 Thousand USD | -6.92% |
| 2006 Q3 | 550.24 Thousand USD | 54.14% |
| 2005 FY | 408.62 Thousand USD | 85.48% |
| 2005 Q1 | 200.21 Thousand USD | -9.12% |
| 2005 Q2 | 199.43 Thousand USD | -0.39% |
| 2005 Q3 | 463.23 Thousand USD | 132.28% |
| 2005 Q4 | 408.62 Thousand USD | -11.79% |
| 2004 Q3 | 224.8 Thousand USD | -0.22% |
| 2004 FY | 220.31 Thousand USD | -86.3% |
| 2004 Q2 | 225.3 Thousand USD | 17.67% |
| 2004 Q4 | 220.31 Thousand USD | -2.0% |
| 2004 Q1 | 191.46 Thousand USD | -88.09% |
| 2003 Q3 | 1.95 Million USD | 21.23% |
| 2003 Q4 | 1.6 Million USD | -17.78% |
| 2003 Q2 | 1.61 Million USD | 32.31% |
| 2003 Q1 | 1.21 Million USD | 40.43% |
| 2003 FY | 1.6 Million USD | 85.21% |
| 2002 Q3 | 782.98 Thousand USD | -64.77% |
| 2002 Q4 | 868.09 Thousand USD | 10.87% |
| 2002 FY | 868.09 Thousand USD | -40.78% |
| 2002 Q1 | 1.68 Million USD | 14.7% |
| 2002 Q2 | 2.22 Million USD | 32.17% |
| 2001 Q4 | 1.46 Million USD | -31.85% |
| 2001 FY | 1.46 Million USD | 306.87% |
| 2001 Q3 | 2.15 Million USD | 165.39% |
| 2001 Q2 | 810.48 Thousand USD | 35.16% |
| 2001 Q1 | 599.64 Thousand USD | 66.45% |
| 2000 Q2 | 1.84 Million USD | 22.62% |
| 2000 Q4 | 360.26 Thousand USD | -22.51% |
| 2000 FY | 360.26 Thousand USD | -73.13% |
| 2000 Q3 | 464.92 Thousand USD | -74.83% |
| 2000 Q1 | 1.5 Million USD | 12.4% |
| 1999 Q3 | 1.27 Million USD | 17.59% |
| 1999 Q1 | 980 Thousand USD | -24.37% |
| 1999 Q4 | 1.34 Million USD | 5.51% |
| 1999 Q2 | 1.08 Million USD | 10.2% |
| 1999 FY | 1.34 Million USD | 3.46% |
| 1998 FY | 1.29 Million USD | -8.65% |
| 1998 Q1 | 1.3 Million USD | -8.36% |
| 1998 Q2 | 1.3 Million USD | 0.0% |
| 1998 Q3 | 1.4 Million USD | 7.69% |
| 1998 Q4 | 1.29 Million USD | -7.44% |
| 1997 Q4 | 1.41 Million USD | 9.12% |
| 1997 Q2 | 1.6 Million USD | -20.0% |
| 1997 Q1 | 2 Million USD | 0.0% |
| 1997 FY | 1.41 Million USD | -30.81% |
| 1997 Q3 | 1.3 Million USD | -18.75% |
| 1996 FY | 2.05 Million USD | -53.62% |
| 1996 Q1 | 2.5 Million USD | -19.35% |
| 1996 Q2 | 2.96 Million USD | 18.57% |
| 1996 Q3 | 2.3 Million USD | -22.41% |
| 1995 Q4 | 3.1 Million USD | -18.42% |
| 1995 Q1 | 4.6 Million USD | 0.0% |
| 1995 FY | 4.42 Million USD | 16.34% |
| 1995 Q2 | 4.42 Million USD | -3.89% |
| 1995 Q3 | 3.8 Million USD | -14.05% |
| 1994 Q2 | 3.8 Million USD | 0.0% |
| 1994 Q3 | 4 Million USD | 5.26% |
| 1994 Q1 | 3.8 Million USD | 2.7% |
| 1994 FY | 3.8 Million USD | 35.71% |
| 1993 Q4 | 3.7 Million USD | 23.33% |
| 1993 FY | 2.8 Million USD | 180.0% |
| 1993 Q3 | 3 Million USD | 7.14% |
| 1993 Q2 | 2.8 Million USD | 55.56% |
| 1993 Q1 | 1.8 Million USD | 50.0% |
| 1992 FY | 1 Million USD | 900.0% |
| 1992 Q3 | 1.4 Million USD | 40.0% |
| 1992 Q2 | 1 Million USD | 0.0% |
| 1992 Q4 | 1.2 Million USD | -14.29% |
| 1991 Q4 | 600 Thousand USD | 0.0% |
| 1991 FY | 100 Thousand USD | -50.0% |
| 1991 Q2 | 100 Thousand USD | 0.0% |
| 1990 Q3 | 300 Thousand USD | 50.0% |
| 1990 Q2 | 200 Thousand USD | 0.0% |
| 1990 FY | 200 Thousand USD | -50.0% |
| 1989 FY | 400 Thousand USD | 0.0% |
| 1989 Q2 | 400 Thousand USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 126.59 Million USD | 40.718% |
| AngioDynamics, Inc. | 112.08 Million USD | 33.041% |
| AtriCure, Inc. | 147.76 Million USD | 49.209% |
| Avinger, Inc. | 19.97 Million USD | -275.781% |
| Azenta, Inc. | 351.22 Million USD | 78.631% |
| The Cooper Companies, Inc. | 4.1 Billion USD | 98.173% |
| Daxor Corporation | 858.75 Thousand USD | -8639.482% |
| Ekso Bionics Holdings, Inc. | 16.31 Million USD | -360.097% |
| Femasys Inc. | 9.4 Million USD | -698.14% |
| GlucoTrack, Inc. | 1.7 Million USD | -4294.087% |
| Harvard Bioscience, Inc. | 64.29 Million USD | -16.735% |
| Hologic, Inc. | 4.02 Billion USD | 98.136% |
| ICU Medical, Inc. | 2.25 Billion USD | 96.672% |
| Intuitive Surgical, Inc. | 2.04 Billion USD | 96.329% |
| KORU Medical Systems, Inc. | 8.1 Million USD | -825.733% |
| LeMaitre Vascular, Inc. | 48.87 Million USD | -53.548% |
| Innovative Eyewear, Inc. | 659.93 Thousand USD | -11272.466% |
| Innovative Eyewear, Inc. | 659.93 Thousand USD | -11272.466% |
| Masimo Corporation | 1.67 Billion USD | 95.524% |
| Microbot Medical Inc. | 3.82 Million USD | -1861.605% |
| Meihua International Medical Technologies Co., Ltd. | 25.07 Million USD | -199.277% |
| Merit Medical Systems, Inc. | 1.12 Billion USD | 93.318% |
| Nephros, Inc. | 3.5 Million USD | -2042.478% |
| NovoCure Limited | 783.63 Million USD | 90.423% |
| NEXGEL, Inc. | 4.78 Million USD | -1467.154% |
| NEXGEL, Inc. | 4.78 Million USD | -1467.154% |
| Singular Genomics Systems, Inc. | 86.46 Million USD | 13.197% |
| OraSure Technologies, Inc. | 52.17 Million USD | -43.848% |
| Pro-Dex, Inc. | 23.34 Million USD | -221.514% |
| Pulse Biosciences, Inc. | 16.44 Million USD | -356.404% |
| Predictive Oncology Inc. | 6.14 Million USD | -1121.241% |
| Precision Optics Corporation, Inc. | 6.84 Million USD | -996.47% |
| QuidelOrtho Corporation | 3.55 Billion USD | 97.89% |
| Repligen Corporation | 853.2 Million USD | 91.204% |
| Sanara MedTech Inc. | 29.28 Million USD | -156.294% |
| STAAR Surgical Company | 102.73 Million USD | 26.949% |
| Sharps Technology, Inc. | 3.85 Million USD | -1846.857% |
| Utah Medical Products, Inc. | 7.14 Million USD | -950.399% |
| DENTSPLY SIRONA Inc. | 4.07 Billion USD | 98.159% |
| Jin Medical International Ltd. | 8.92 Million USD | -740.969% |